Rover Diagnostics Receives $1.8M New York State Biodefense Award


Posted October 30, 2024 by roverdx

Rover Diagnostics Receives $1.8M New York State Biodefense Award to Develop a Platform for Rapid Diagnostic Development, Response, and Surveillance

 
New York State Biodefense Commercialization Fund awarded Rover Diagnostics $1.8 million to develop an Affordable and Adaptable real-time Nucleic Acid Amplification Test (NAAT) platform for Rapid Diagnostic Development, Response, and Surveillance.

Since 2019, Rover has been developing the LightSpeed, a sample to answer molecular diagnostic testing solution for use in decentralized settings. The LightSpeed integrates lab based methodologies with multiplex capabilities for future test menu expansion capabilities. The unique technology provides rapid sample processing in
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Maliha Momtaj
Phone 646-577-0859
Business Address Rover Diagnostics 3960 Broadway, New York, NY 10032
Country United States
Categories Biotech , Health , Medical
Tags lab testing , rapid diagnostics , molecular diagnostics , biothreat surveillance
Last Updated October 30, 2024